Prognostic relevance of MLH1 and MSH2 mutations in hereditary non-polyposis colorectal cancer patients

Tumori

Volumn 95, Issue 6, 2009, Pages 731-738

  Russo, Antonio ^a   Sala, Paola ^b   Alberici, Paola ^b   Gazzoli, Isabella ^b   Radice, Paolo ^b   Montefusco, Claudia ^b   Torrini, Margherita ^c   Mareni, Cristina ^c   Fornasarig, Mara ^d   Santarosa, Manuela ^d   Viel, Alessandra ^d   Benatti, Piero ^e   Pedroni, Maurizio ^e   Ponz De Leon, Maurizio ^e   Lucci Cordisco, Emanuela ^f   Genuardi, Maurizio ^g   Messerini, Luca ^g   Stigliano, Vittoria ^h   Cama, Alessandro ⁱ   Curia, Maria Cristina ⁱ   De Lellis, Laura ⁱ   Signoroni, Stefano ^b   Pierotti, Marco A ^b,j   Bertario, Lucio ^b   more..

^a SAN CARLO BORROMEO HOSPITAL   (Italy)

^b NATIONAL CANCER INSTITUTE   (Italy)

^c UNIVERSITY OF GENOA   (Italy)

^d CENTRO DI RIFERIMENTO ONCOLOGICO   (Italy)

^e UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^f CANCER RESEARCH AND PREVENTION INSTITUTE ISPO   (Italy)

^g UNIVERSITY OF FLORENCE   (Italy)

^h REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

ⁱ UNIVERSITY OF CHIETI   (Italy)

^j FIRC INSTITUTE OF MOLECULAR ONCOLOGY   (Italy)

more..

Author keywords

Hereditary non polyposis colorectal cancer; MLH1; MSH2; Survival

Indexed keywords

PROTEIN MLH1; PROTEIN MSH2;

ADULT; AGED; ARTICLE; CANCER STAGING; CANCER SURVIVAL; COLORECTAL CANCER; CONTROLLED STUDY; DISEASE MARKER; FEMALE; GENE MUTATION; GENETIC HETEROGENEITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MICROSATELLITE INSTABILITY; PROGNOSIS; TUMOR LOCALIZATION;

EID: 76349089323     PISSN: 03008916     EISSN: None     Source Type: Journal    
DOI: 10.1177/030089160909500616     Document Type: Article

References (57)

1. de la Chapelle A: Genetic predisposition to colorectal cancer. Nat Rev Cancer, 4: 769-780, 2004.
2. Lynch HT, de la Chapelle A: Hereditary colorectal cancer. N Engl J Med, 348: 919-932, 2003.
3. Vasen HF, Mecklin JP, Meera Khan P, Lynch HT: The International Collaborative Group on Hereditary Non-Polyposis Colorectal cancer (ICG-HNPCC). Dis Colon Rectum, 34: 424-425, 1991.
4. Vasen HF, Watson P, Mecklin IP, Lynch HT: New clinical criteria for hereditary nonpolyposis colorectal cancer (HN-PCC, Lynch syndrome) proposed by the International Collaborative group on HNPCC. Gastroenterology, 116: 1453-1456, 1999.
5. Jo WS, Chung DC: Genetics of hereditary colorectal cancer. Semin Oncol, 32: 11-23, 2005.
6. Jass JR, Whitehall VL, Young J, Leggett BA: Emerging concepts in colorectal neoplasia. Gastroenterology, 123: 862-876, 2002.
7. Kinzler KW, Vogelstein B: Lessons from hereditary colorectal cancer. Cell, 87: 159-170, 1996.
8. Popat S, Hubner R, Houlston RS: Systematic review of microsatellite instability and colorectal cancer prognosis. J Clin Oncol, 23: 609-618, 2005.
9. Albano WA, Recabaren JA, Lynch HT, Campbell AS, Mailliard JA, Organ CH, Lynch JF, Kimberling WJ: Natural history of hereditary cancer of the breast and colon. Cancer, 50: 360-363, 1982.
10. Fujita S, Moriya Y, Sugihara K, Akasu T, Ushio K: Prognosis of hereditary nonpolyposis colorectal cancer (HNPCC) and the role of Japanese criteria for HNPCC. Jpn J Cancer Res, 26: 351-355, 1996.
11. Myrhøj T, Bisgaard ML, Bernstein I, Svendsen LB, Sønder-gaard JO, Billow S: Hereditary non-polyposis colorectal cancer: clinical features and survival. Results from the Danish HNPCC register. Scand J Gastroenterol, 32: 572-576, 1997.
12. Aarnio M, Mustonen H, Mecklin JP, Järvinen HJ: Prognosis of colorectal cancer varies in different high-risk conditions. Ann Med, 30: 75-80, 1998.
13. Watson P, Lin KM, Rodriguez-Bigas MA, Smyrk T, Lemon S, Shashidharan M, Franklin B, Karr B, Thorson A, Lynch HT: Colorectal carcinoma survival among hereditary nonpolyposis colorectal carcinoma family members. Cancer, 83: 259-266, 1998.
14. Percesepe A, Benatti P, Roncucci L, Sassatelli R, Fante R, Ganazzi D, Bellacosa A, Genuardi M, Neri G, Viel A, Ponz de Leon M: Survival analysis in families affected by hereditary non-polyposis colorectal cancer. Int J Cancer, 71: 373-376, 1997.
15. Bertario L, Russo A, Sala P, Eboli M, Radice P, Presciuttini S, Andreola S, Rodriguez-Bigas MA, Pizzetti P, Spinelli P: Survival of patients with hereditary colorectal cancer: comparison of HNPCC and colorectal cancer in FAP patients with sporadic colorectal cancer. Int J Cancer, 80: 183-187, 1999.
16. Bermejo JL, Eng C, Hemminki K: Cancer characteristics in Swedish families fulfilling criteria for hereditary nonpolyposis colorectal cancer. Gastroenterology, 129: 1889-1899, 2005.
17. Farrington SM, McKinley AJ, Carothers AD, Cunningham C, Bubb VJ, Sharp L, Wyllie AH, Dunlop MG: Evidence for an age-related influence of microsatellite instability on colorectal cancer survival. Int J Cancer, 98: 844-850, 2002.
18. Sankila R, Aaltonen LA, Järvinen HJ, Mecklin JP: Better survival rates in patients with MLH1-associated hereditary colorectal cancer. Gastroenterology, 110: 682-687, 1996.
19. Barnetson RA, Tenesa A, Farrington SM, Nicholl ID, Cetnarskyj R, Porteous ME, Campbell H, Dunlop MG: Identification and survival of carriers of mutations in DNA mismatch-repair genes in colon cancer. N Engl J Med, 354: 2815-2817, 2006.
20. Jass JR, Morson BC: Reporting colorectal cancer. J Clin Pathol, 40: 1016-1023, 1987.
21. Pensotti V, Radice P, Presciuttini S, Calistri D, Gazzoli I, Grimait Perez A, Mondini P, Buonsanti G, Sala P, Rossetti C, Ranzani GN, Bertario L, Pierotti MA: Mean age of tumor onset in hereditary non-polyposis colorectal cancer (HN-PCC) families correlates with the presence of mutations in DNA mismatch repair gene. Genes Chromosomes Cancer, 19: 135-142, 1997.
22. Viel A, Genuardi M, Capozzi E, Leonardi F, Bellacosa A, Paravatou-Petsotas M, Pomponi MG, Fornasarig M, Percesepe A, Roncucci L, Tamassia MG, Benatti P, Ponz de Leon M, Valenti A, Covino M, Anti M, Foletto M, Boiocchi M, Neri G: Characterization of MSH2 and MLH1 mutations in Italian families with hereditary nonpolyposis colorectal cancer. Genes Chromosomes Cancer, 18: 8-18, 1997.
23. Curia MC, Palmirotta R, Aceto G, Messerini L, Verì MC, Crognale S, Valanzano R, Ficari F, Fracasso P, Stigliano V, Tonelli F, Casale V, Guadagni F, Battista P, Mariani-Costantini R, Cama A: Unbalanced germ-line expression of hMLH1 and hMSH2 alleles in hereditary nonpolyposis colorectal cancer. Cancer Res, 59: 3570-3575, 1999.
24. Montera M, Resta N, Simone C, Guanti G, Marchese C, Civitelli S, Mancini A, Pozzi S, De Salvo L, Bruzzone D, Donadini A, Romio L, Mareni C: Mutational germline analysis of hMSH2 and hMLH1 genes in early onset colorectal cancer patients. J Med Genet, 40: 472, 2000.
25. Wijnen J, Vasen H, Meera Khan P, Menko FH, Van Der Klift H, Van Leeuwen C, Van Den Broek M, Van Leeuwen-Cornelisse I, Nagengast F, Meijers-Heijboer A, Lindhout D, Griffioen G, Cats A, Kleibeuker J, Varesco L, Bertario L, Bisgaard ML, Mohr J, Fodde R: Seven new mutations in hMSH2, an HNPCC gene, identified by denaturing gradient gel electrophoresis. Am J Hum Genet, 56: 1060-1066, 1995.
26. Wijnen J, Khan PM, Vasen H, Menko F, van der Klift H, van den Broek M, van Leeuwen-Cornelisse I, Nagengast F, Meijers-Heijboer EJ, Lindhout D, Griffioen G, Cats A, Kleibeuker J, Varesco L, Bertario L, Bisgaard ML, Mohr J, Kolodner R, Fodde R: Majority of hMLH1 mutations responsible for hereditary nonpolyposis colorectal cancer cluster at the exonic region 15-16. Am J Hum Genet, 58: 300-307, 1996.
27. Holinski-Feder E, Müller-Koch Y, Friedl W, Moeslein G, Keller G, Plaschke J, Ballhausen W, Gross M, Baldwin-Jedele K, Jungck M, Mangold E, Vogelsang H, Schackert HK, Lohsea P, Murken J, Meitinger T: DHPLC mutation analysis of the hereditary nonpolyposis colon cancer (HNPCC) genes hMLH1 and hMSH2. J Biochem Biophys Methods, 47: 21-32, 2001.
28. Viel A, Petronzelli F, Della Puppa L, Lucci-Cordisco E, Fornasarig M, Pucciarelli S, Rovella V, Quaia M, Ponz de Leon M, Boiocchi M, Genuardi M: Different molecular mechanisms underlie genomic deletions in the MLH1 Gene. Hum Mutat, 20: 368-374, 2002.
29. Pastrello C, Baglioni S, Tibiletti MG, Papi L, Fornasarig M, Morabito A, Agostini M, Genuardi M, Viel A: Stability of BAT26 in tumours of hereditary nonpolyposis colorectal cancer patients with MSH2 intragenic deletion. Eur J Hum Genet, 14: 63-68, 2006.
30. De Lellis L, Curia MC, Catalano T, De Toffol S, Bassi C, Mareni C, Bertario L, Battista P, Mariani-Costantini R, Radice P, Cama A: Combined use of MLPA and non-fluorescent multiplex PCR analysis by high performance liquid chromatography (NFMP-HPLC) for the detection of genomic rearrangements. Hum Mutat, 27: 1047-1056, 2006.
31. Boland CR, Thibodeau SN, Hamilton SR, Sidransky D, Eshleman JR, Burt RW, Meltzer SJ, Rodriguez-Bigas MA, Fodde R, Ranzani GN, Srivastava S: A National Cancer Institute workshop on microsatellite instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res, 58: 5248-5257, 1998.
32. Canzian F, Salovaara R, Hemminki A, Kristo P, Chadwick RB, Aaltonen LA, de la Chapelle A: Semiautomated assessment of loss of heterozygosity and replication error in tumors. Cancer Res, 564: 3331-3337, 1996.
33. Bertario L, Aste H, Arrigoni A, Fracasso P, Rossini FP, Rossetti C, Valanzano R: Clinical aspects and management of hereditary non-polyposis colorectal cancer (HNPCC). Tumori, 82: 117-121, 1996.
34. Clark AJ, Barnetson R, Farrington SM, Dunlop MG: Prognosis in DNA mismatch repair deficient colorectal cancer: are all MSI tumours equivalent? Fam Cancer, 3: 85-91, 2004.
35. Benatti P, Roncucci L, Ganazzi D, Percesepe A, Di Gregorio C, Pedroni M, Borghi F, Sala E, Scarselli A, Menigatti M, Rossi G, Genuardi M, Viel A, Ponz De Leon M: Clinical and biologic heterogeneity of hereditary nonpolyposis colorec-tal cancer. Int J Cancer, 95: 323-328, 2001.
36. Ribic CM, Sargent DJ, Moore MJ, Thibodeau SN, French AJ, Goldberg RM, Hamilton SR, Laurent-Puig P, Gryfe R, Shepherd LE, Tu D, Redston M, Gallinger S: Tumor microsatellite-instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancer. N Engl J Med, 349: 247-257, 2003.
37. Carethers JM, Smith EJ, Behling CA, Nguyen L, Tajima A, Doctolero RT, Cabrera BL, Goel A, Arnold CA, Miyai K, Boland CR: Use of 5-fluorouracil and survival in patients with microsatellite-unstable colorectal cancer. Gastroenterology, 126: 394-401, 2004.
38. de Vos tot Nederveen Cappel WH, Meulenbeld HJ, Kleibeuker JH, Nagengast FM, Menko FH, Griffioen G, Cats A, Morreau H, Gelderblom H, Vasen HF: Survival after adjuvant 5-FU treatment for stage III colon cancer in hereditary nonpolyposis colorectal cancer. Int J Cancer, 109: 468-471, 2004.
39. Benatti P, Gafà R, Barana D, Marino M, Scarselli A, Pedroni M, Maestri I, Guerzoni L, Roncucci L, Menigatti M, Roncari B, Maffei S, Rossi G, Ponti G, Santini A, Losi L, Di Gregorio C, Oliani C, Ponz de Leon M, Lanza G: Microsatellite instability and colorectal cancer prognosis. Clin Cancer Res, 11: 8332-8340, 2005.
40. Warusavitarne J, Ramanathan P, Kaufman A, Robinson BG, Schnitzler M: 5-fluorouracil (5FU) treatment does not influence invasion and metastasis in microsatellite unstable (MSI-H) colorectal cancer. Int J Colorectal Dis, 21: 625-631, 2006.
41. Dolcetti R, Viel A, Doglioni C, Russo A, Guidoboni M, Capozzi E, Vecchiato N, Macrì E, Fornasarig M, Boiocchi M: High prevalence of activated intraepithelial cytotoxic T lymphocytes and increased neoplastic cell apoptosis in colorectal carcinomas with microsatellite instability. Am J Pathol, 154: 1805-1813, 1999.
42. Michael-Robinson JM, Biemer-Hüttmann A, Purdie DM, Walsh MD, Simms LA, Biden KG, Young JP, Leggett BA, Jass JR, Radford-Smith GL: Tumour infiltrating lymphocytes and apoptosis are independent features in colorectal cancer stratified according to microsatellite instability status. Gut, 48: 360-366, 2001.
43. Smyrk TC, Watson P, Kaul K, Lynch HT: Tumor-infiltrating lymphocytes are a marker for microsatellite instability in colorectal carcinoma. Cancer, 91: 2417-2422 2001.
44. Wynter CV, Simms LA, Buttenshaw RL, Biden KG, Young J, Leggett BA, Conrad RJ, Schoch EM, Jass JR, Praga Pillay S: Angiogenic factor VEGF is decreased in human colorectal neoplasms showing DNA microsatellite instability. J Pathol, 189: 319-325, 1999.
45. Wendum D, Boëlle PY, Rigau V, Sebbagh N, Olschwang S, Mourra N, Parc R, Trugnan G, Masliah J, Fléjou JF: Mucinous colon carcinomas with microsatellite instability have a lower microvessel density and lower vascular endothelial growth factor expression. Virchows Arch, 442: 111-117, 2003.
46. Inoue Y, Miki C, Watanabe H, Ojima E, Kusunoki M: Genomic instability and tissue expression of angiogenic growth factors in sporadic colorectal cancer. Surgery, 139: 305-311, 2006.
47. Buckowitz A, Knaebel HP, Benner A, Bläker H, Gebert J, Kienle P, von Knebel Doeberitz M, Kloor M: Microsatellite instability in colorectal cancer is associated with local lymphocyte infiltration and low frequency of distant metastases. Br J Cancer, 92: 1746-1753, 2005.
48. Chung D, Rustgi AK: The hereditary nonpolyposis colorectal cancer syndrome: genetics and clinical implications. Ann Intern Med, 138: 560-570, 2003.
49. Graziano F, Cascinu S: Prognostic molecular markers for planning adjuvant chemotherapy trials in Dukes' B colorectal cancer patients: how much evidence is enough? Ann Oncol, 14: 1026-1038, 2003.
50. Klump B, Nehls O, Okech T, Hsieh CJ, Gaco V, Gittinger FS, Sarbia M, Borchard F, Greschniok A, Gruenagel HH, Porschen R, Gregor M: Molecular lesions in colorectal cancer: impact on prognosis? Original data and review of the literature. Int J Colorectal Dis, 19: 23-42, 2004.
51. Lindor NM, Rabe K, Petersen GM, Haile R, Casey G, Baron J, Gallinger S, Bapat B, Aronson M, Hopper J, Jass J, LeMarchand L, Grove J, Potter J, Newcomb P, Terdiman JP, Conrad P, Moslein G, Goldberg R, Ziogas A, Anton-Culver H, de Andrade M, Siegmund K, Thibodeau SN, Boardman LA, Seminara D: Lower cancer incidence in Amsterdam-I criteria families without mismatch repair deficiency. JAMA, 293: 1979-1985, 2005.
52. Abdel-Rahman WM, Ollikainen M, Kariola R, Järvinen HJ, Mecklin JP, Nyström-Lahti M, Knuutila S, Peltomäki P: Comprehensive characterization of HNPCC-related colorectal cancers reveals striking molecular features in families with no germline mismatch repair gene mutations. Oncogene, 24: 1542-1551, 2005.
53. Llor X, Pons E, Xicola RM, Castells A, Alenda C, Piñol V, Andreu M, Castellví-Bel S, Payá A, Jover R, Bessa X, Girós A, Roca A, Gassull MA: Differential features of colorectal cancers fulfilling Amsterdam criteria without involvement of the mutator pathway. Clin Cancer Res, 11: 7304-7310, 2005.
54. Mueller-Koch Y, Vogelsang H, Kopp R, Lohse P, Keller G, Aust D, Muders M, Gross M, Daum J, Schiemann U, Grabowski M, Scholz M, Kerker B, Becker I, Henke G, Holinski-Feder E: Hereditary non-polyposis colorectal cancer: clinical and molecular evidence for a new entity of hereditary colorectal cancer. Gut, 54: 1733-1740, 2005.
55. Lynch HT, Boland CR, Gong G, Shaw TG, Lynch PM, Fodde R, Lynch JF, de la Chapelle A: Phenotypic and genotypic heterogeneity in the Lynch syndrome: diagnostic, surveillance and management implications. Eur J Hum Genet, 14: 390-402, 2006.
56. Dove-Edwin I, de Jong AE, Adams J, Mesher D, Lipton L, Sasieni P, Vasen HF, Thomas HJ: Prospective results of surveillance colonscopy in dominant familial colorectal cancer with and without Lynch syndrome. Gastroenterology, 130: 1995-2000, 2006.
57. Travis LB, Rabkin CS, Brown LM, Allan JM, Alter BP, Ambrosone CB, Begg CB, Caporaso N, Chanock S, DeMichele A, Figg WD, Gospodarowicz MK, Hall EJ, Hisada M, Inskip P, Kleinerman R, Little JB, Malkin D, Ng AK, Offit K, Pui CH, Robison LL, Rothman N, Shields PG, Strong L, Taniguchi T, Tucker MA, Greene MH: Cancer survivorship - genetic susceptibility and second primary cancers: research strategies and recommendations. J Natl Cancer Inst, 98: 15-25, 2006.